Gene Therapy for the Treatment of Infectious Diseases

Gene therapy confines considerable potential for the treatment of both infectious diseases and hereditary genetic disorders. Human gene therapy is defined as the presentation of new genetic material into the cells of a person with the purpose of generating a therapeutic advantage for the patient. Gene therapy is being researched as an alternative for a number of infectious diseases that does not agree to the standard clinical administration. Gene therapy for infectious diseases needs the introduction of genes outlined to particularly repress or block the gene expression or function of gene products, to such an extent that the replication of the infectious agent is blocked or constrained. In addition to this intracellular interference, gene therapy may be used to mediate in the spread of the infectious agent at the extracellular level. This could be accomplished by sustained expression in vivo of a discharged inhibitory protein or stimulation of a specific immune response.

  • Molecular therapy
  • Nucleic Acid-Based Genetic Therapy
  • Protein-Based Approaches to Gene Therapy
  • Immunotherapy
  • Target Pathogens for Antimicrobial Gene Therapy

Related Conference of Gene Therapy for the Treatment of Infectious Diseases

June 02-03, 2025

14th World Congress on Rare Diseases and Orphan Drugs

Amsterdam, Netherlands
June 02-03, 2025

17th Euro-Global Conference on Infectious Diseases

Amsterdam, Netherlands
August 28-29, 2025

8th Pathology and Infectious Disease Conference

London, UK
September 22-23, 2025

11th International Conference on Infectious and Rare Diseases

Vancouver, Canada
December 11-12, 2025

8th Annual Congress on Bacterial, Viral and Infectious Diseases

Prague, Czech Republic

Gene Therapy for the Treatment of Infectious Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in